These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8143257)
1. Effect of repeated administration of tirilazad mesylate on healthy and endotoxemic calves: a pilot study. Semrad SD; Dubielzig R Can J Vet Res; 1994 Jan; 58(1):67-70. PubMed ID: 8143257 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of tirilazad mesylate for treatment of endotoxemia in neonatal calves. Rose ML; Semrad SD Am J Vet Res; 1992 Dec; 53(12):2305-10. PubMed ID: 1476313 [TBL] [Abstract][Full Text] [Related]
3. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves. Semrad SD; Rose ML; Adams JL Circ Shock; 1993 Aug; 40(4):235-42. PubMed ID: 8375024 [TBL] [Abstract][Full Text] [Related]
4. Effect of endotoxin on tirilazad mesylate (U74006F) pharmacokinetic parameters in neonatal calves. Rose ML; Semrad SD; Putnam ML; Brown SA J Vet Pharmacol Ther; 1993 Dec; 16(4):438-45. PubMed ID: 8126760 [TBL] [Abstract][Full Text] [Related]
5. Effects of N-acetylcysteine and tirilazad mesylate on intestinal functional capillary density, leukocyte adherence, mesenteric plasma extravasation and cytokine levels in experimental endotoxemia in rats. Birnbaum J; Lehmann Ch; Klotz E; Hein OV; Blume A; Jubin F; Polze N; Luther D; Spies CD Clin Hemorheol Microcirc; 2008; 39(1-4):99-111. PubMed ID: 18503116 [TBL] [Abstract][Full Text] [Related]
6. Effect of phenylbutazone and repeated endotoxin administration on hemostasis in neonatal calves. Semrad SD; Dubielzig R Am J Vet Res; 1993 Aug; 54(8):1339-46. PubMed ID: 8214907 [TBL] [Abstract][Full Text] [Related]
7. Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5). Morris DD; Cullor JS; Whitlock RH; Wickstrom M; Corbeil LB Am J Vet Res; 1986 Dec; 47(12):2554-65. PubMed ID: 3541706 [TBL] [Abstract][Full Text] [Related]
8. Hematology of the neonatal calf. II. Response associated with acute enteric infections, gram-negative septicemia, and experimental endotoxemia. Tennant B; Harrold D; Reina-Guerra M Cornell Vet; 1975 Oct; 65(4):457-75. PubMed ID: 1104259 [TBL] [Abstract][Full Text] [Related]
9. The combinations C1 esterase inhibitor with coagulation factor XIII and N-acetylcysteine with tirilazad mesylate reduce the leukocyte adherence in an experimental endotoxemia in rats. Birnbaum J; Klotz E; Spies CD; Hein OV; Mallin K; Kawka R; Ziemer S; Lehmann C Clin Hemorheol Microcirc; 2008; 40(3):167-76. PubMed ID: 19029642 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of an Escherichia coli J-5 mutant strain bacterin in the protection of calves from endotoxin disease caused by subcutaneous challenge with endotoxins from Escherichia coli. Deluyker HA; Rossitto P; Van Oye SN; Cullor JS Vaccine; 2004 Dec; 23(5):709-17. PubMed ID: 15542194 [TBL] [Abstract][Full Text] [Related]
11. Comparison of flunixin, prednisolone, dimethyl sulfoxide, and a lazaroid (U74389F) for treating endotoxemic neonatal calves. Semrad SD Am J Vet Res; 1993 Sep; 54(9):1517-22. PubMed ID: 8239143 [TBL] [Abstract][Full Text] [Related]
12. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage. Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254 [TBL] [Abstract][Full Text] [Related]
13. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Matsui T; Asano T Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration. Fleishaker JC; Peters GR; Cathcart KS; Steenwyk RC J Clin Pharmacol; 1993 Feb; 33(2):182-90. PubMed ID: 8440768 [TBL] [Abstract][Full Text] [Related]
15. Respiratory, renal, hematologic, and serum biochemical effects of hypertonic saline solution in endotoxemic calves. Constable PD; Schmall LM; Muir WW; Hoffsis GF Am J Vet Res; 1991 Jul; 52(7):990-8. PubMed ID: 1892279 [TBL] [Abstract][Full Text] [Related]
16. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Gerros TC; Semrad SD; Proctor RA; LaBorde A Am J Vet Res; 1993 Dec; 54(12):2121-7. PubMed ID: 8116949 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-induced attenuation of cardiopulmonary dysfunction in endotoxemic calves. Olson NC; Brown TT Am J Vet Res; 1986 Oct; 47(10):2187-92. PubMed ID: 3777644 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration. Fleishaker JC; Peters GR; Cathcart KS J Clin Pharmacol; 1993 Feb; 33(2):175-81. PubMed ID: 8382708 [TBL] [Abstract][Full Text] [Related]
19. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Durando MM; MacKay RJ; Linda S; Skelley LA Am J Vet Res; 1994 Jul; 55(7):921-7. PubMed ID: 7978630 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor as a potential mediator of acute metabolic and hormonal responses to endotoxemia in calves. Kenison DC; Elsasser TH; Fayer R Am J Vet Res; 1991 Aug; 52(8):1320-6. PubMed ID: 1928916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]